Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, December 4, 2019
[ Wed, Dec 04th 2019
] - WOPRAI
[ Wed, Dec 04th 2019
] - WOPRAI
[ Wed, Dec 04th 2019
] - WOPRAI
[ Wed, Dec 04th 2019
] - WOPRAI
[ Wed, Dec 04th 2019
] - WOPRAI
[ Wed, Dec 04th 2019
] - WOPRAI
[ Wed, Dec 04th 2019
] - WOPRAI
[ Wed, Dec 04th 2019
] - WOPRAI
[ Wed, Dec 04th 2019
] - WOPRAI
[ Wed, Dec 04th 2019
] - WOPRAI
[ Wed, Dec 04th 2019
] - WOPRAI
[ Wed, Dec 04th 2019
] - WOPRAI
Tue, December 3, 2019
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
[ Tue, Dec 03rd 2019
] - WOPRAI
Matthew Luchini Downgraded (BOLD) to Hold and Increased Target to $60 on, Dec 3rd, 2019
Matthew Luchini of BMO Capital, Downgraded "Boundless Bio, Inc." (BOLD) to Hold and Increased Target from $47 to $60 on, Dec 3rd, 2019.
Matthew has made no other calls on BOLD in the last 4 months.
There is 1 other peer that has a rating on BOLD. Out of the 1 peers that are also analyzing BOLD, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $40 on, Tuesday, November 19th, 2019
